Clinical Pediatrics

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to browse AJSM online!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brown, R. T.
Right arrow Articles by Sexson, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brown, R. T.
Right arrow Articles by Sexson, S. B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Clinical Pediatrics, Vol. 27, No. 2, 74-81 (1988)
DOI: 10.1177/000992288802700204

A Controlled Trial of Methylphenidate in Black Adolescents

Attentional, Behavioral, and Physiological Effects

Ronald T. Brown, PhD

Division of Child and Adolescent Psychiatry, Emory University School of Medicine, Atlanta, Georgia

Sandra B. Sexson, MD

Division of Child and Adolescent Psychiatry, Emory University School of Medicine, Atlanta, Georgia

The short-term effects of methylphenidate were examined on behavioral, laboratory, academic, and physiological measures in 11 black male adolescents diagnosed as having attention deficit disorder (ADD). In a double-blind, crossover design with randomized order, the subjects received placebo and each of three methylphenidate doses (0.15 mg/kg, 0.30 mg/kg, and 0.50 mg/kg) for a period of 2 weeks per medication dosage. Significant drug effects were found for the majority of measures. In general, the higher doses resulted in the most beneficial response in behavioral, academic, and laboratory measures of attention and impulsivity. However, a significant linear increase occurred in diastolic blood pressure. The results suggest that methylphenidate is an effective adjunct to the treatment of ADD in adolescents.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J Atten DisordHome page
H. Hervey-Jumper, K. Douyon, T. Falcone, and K. N. Franco
Identifying, Evaluating, Diagnosing, and Treating ADHD in Minority Youth
J Atten Disord, March 1, 2008; 11(5): 522 - 528.
[Abstract] [PDF]

Home page
 PediatricsHome page
T. E. Wilens, J. B. Prince, T. J. Spencer, and J. Biederman
Stimulants and Sudden Death: What Is a Physician to Do?
Pediatrics, September 1, 2006; 118(3): 1215 - 1219.
[Abstract] [Full Text] [PDF]

Home page
 J Atten DisordHome page
L. A. Hazel-Fernandez, R. Klorman, J. M. Wallace, and S. Cook
Methylphenidate improves aspects of executive function in african american children with ADHD.
J Atten Disord, May 1, 2006; 9(4): 582 - 589.
[Abstract] [PDF]

Home page
 J Atten DisordHome page
V.J. Samuel, S. Curtis, A. Thornell, P. George, A. Taylor, D. R. Brome, J. Biederman, and S.V. Faraone
The unexplored void of ADHD and African-American research: A review of the literature
J Atten Disord, January 1, 1997; 1(4): 197 - 207.
[Abstract]

Home page
 Journal of Pharmacy PracticeHome page
L. K. Laird and J. J. Saklad
Attention-Deficit Hyperactivity Disorder
Journal of Pharmacy Practice, January 1, 1990; 3(4): 241 - 251.
[Abstract] [PDF]